Anti-oxidized LDL antibody levels are reduced in women with hypertension

European Journal of Clinical Investigation

Volumn 39, Issue 9, 2009, Pages 800-806

  Garrido Sanchez L ^a,b,e   Garcia Fuentes E ^a,b,c,d   Cardona, F ^a,b,c   Rojo Martinez G ^a,c,d   Soriguer, F ^a,d   Tinahones, F J ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b H Virgen de la Victoria   (Spain)

^c MABIS Foundation   (Spain)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Anti oxidized low density lipoprotein antibodies; Atherosclerosis; Hypertension; Low density lipoprotein; Oxidized low density lipoprotein

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOGLOBULIN G ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; ATHEROSCLEROSIS; AUTOANTIBODIES; FEMALE; HUMANS; HYPERTENSION; LIPOPROTEINS, LDL; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; YOUNG ADULT;

EID: 68349152229     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02156.x     Document Type: Article

References (30)

1. MacMahon SW, Peto R, Cutler J, Collins R, Sorlie P, Neaton J et al. Blood pressure, stroke and coronary heart disease: part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990 335 : 765 9.
2. Maggi E, Marchesi E, Ravetta V, Falaschi F, Finardi G, Bellomo G. Low-density lipoprotein oxidation in essential hypertension. J Hypertens 1993 11 : 1103 11.
3. Nichols WW, O′Rourke MF. Hipertension. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. London : Arnold 1998. pp. 377 95.
4. Inoue N, Kawashima S, Hirata KI, Rikitake Y, Takeshita S, Yamochi W et al. Stretch force on vascular smooth muscle cells enhances oxidation of LDL via superoxide production. Am J Physiol 1998 274 : H1928 32.
5. Meyer G, Merval R, Tedgui A. Effects of pressure-induced stretch and convection on low-density lipoprotein and albumin uptake in the rabbit aortic wall. Circ Res 1996 79 : 532 40.
6. Toikka JO, Niemi P, Ahotupa M, Niinikoski H, Ronnemaa T, Viikari JS et al. Decreased large artery distensibility in borderline hypertension is related to increased in vivo low-density lipoprotein oxidation. Scand J Clin Lab Invest 2002 62 : 301 6.
7. Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation 1997 95 : 1062 71.
8. Matthys KE, Van HoveCE, Kockx MM, Andries LJ, Van OsselaerN, Herman AG Bult H, et al. Exposure to oxidized low-density lipoprotein in vivo enhances intimal thickening and selectively impairs endothelium-dependent dilation in the rabbit. Cardiovasc Res 1998 37 : 239 46.
9. Toikka JO, Niemi P, Ahotupa M, Niinikoski H, Viikari JS, Ronnemaa T et al. Large-artery elastic properties in young men: relationships to serum lipoproteins and oxidized low-density lipoproteins. Arterioscler Thromb Vasc Biol 1999 19 : 436 41.
10. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992 339 : 883 7.
11. Wu R, de Faire U, Lemne C, Witztum JL, Frostegård J. Autoantibodies to oxLDL are decreased in individuals with borderline hypertension. Hypertension 1999 33 : 53 9.
12. Keidar S, Kaplan M, Shapira C, Brook JG, Aviram M. Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. Atherosclerosis 1994 107 : 71 84.
13. Lacy F, Kailasam MT, O'Connor DT, Schmid-Schonbein GW, Parmer RJ. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 2000 36 : 878 84.
14. Tinahones FJ, Gomez-Zumaquero JM, Rojo-Martinez G, Cardona F, Esteva de Antonio IE, Ruiz de Adana MS et al. Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population. Metabolism 2002 51 : 429 31.
15. Garrido-Sánchez L, Cardona F, García-Fuentes E, Rojo-Martínez G, Gómez-Zumaquero JM, Picón MJ et al. Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus. Eur J Clin Invest 2008 38 : 615 21.
16. Giannattasio C, Failla M, Hennig M, Hollweck R, Laurent S, Mallion JM et al. Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2005 23 : 557 62.
17. Zanchetti A, Bond MG, Hennig M, Tang R, Hollweck R, Mancia G et al. Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2004 22 : 1201 12.
18. Bank AJ, Kaiser DR. Smooth muscle relaxation: effects on arterial compliance, distensibility, elastic modulus, and pulse wave velocity. Hypertension 1998 32 : 356 9.
19. Balada E, Ordi-Ros J, Matas L, Mauri M, Bujan S, Vilardell-Tarres M. Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population. Med Clin (Barc) 2002 119 : 161 5.
20. Stewart-Lee AL, Forster LA, Nourooz-Zadeh J, Ferns GA, Anggard EE. Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. Arterioscler Thromb 1994 14 : 494 9.
21. Lusis AJ, Navab M. Lipoprotein oxidation and gene expression in the artery wall. New opportunities for pharmacologic intervention in atherosclerosis. Biochem Pharmacol 1993 46 : 2119 26.
22. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 362 : 801 9.
23. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989 320 : 915 24.
24. Cardona F, Tunez I, Tasset I, Murri M, Tinahones FJ. Similar increase in oxidative stress after fat overload in persons with baseline hypertriglyceridemia with or without the metabolic syndrome. Clin Biochem 2008 41 : 701 5.
25. Toikka JO, Laine H, Ahotupa M, Haapanen A, Viikari JS, Hartiala JJ et al. Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension 2000 36 : 929 33.
26. Horkko S, Bird DA, Miller E, Itabe H, Leitinger N, Subbanagounder G et al. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 1999 103 : 117 28.
27. Craig W. Autoantibodies against oxidized low density lipoportein: a review of clinical findings and assay methodology. J Clin Lab Anal 1995 9 : 70 4.
28. Shoji T, Nishizawa Y, Fukumoto M, Shimamura K, Kimura J, Kanda H et al. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-ox-LDL antibody levels in healthy subjects. Atherosclerosis 2000 148 : 171 7.
29. Tinahones FJ, Gomez-Zumaquero JM, Garrido-Sanchez L, Garcia-Fuentes E, Rojo-Martinez G, Esteva I et al. Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population. J Lipid Res 2005 46 : 452 7.
30. Garrido-Sánchez L, García-Almeida JM, García-Serrano S, Cardona I, García-Arnes J, Soriguer F et al. The improved carbohydrate metabolism after bariatric surgery raises anti-oxidized LDL antibody levels in morbidly obese patients. Diabetes Care 2008 31 : 2258 64.